P&G Health Q1 FY27 earnings: Net profit surges 45%; revenue grows to ₹364 crore YoY

The growth in profit was led by growth in sales, a strengthened supply chain and go-to-market capabilities, and one-time proceeds from the sale of an immovable asset.

The Mumbai-based company's revenue from operations increased 7% on a year-on-year (YoY) basis to ₹364 crore in the April to June quarter as against ₹339 crore seen in Q1 FY26.

The company said it has delivered sales of ₹356 crore, up 7% versus a year ago, driven by strong brand fundamentals, superior retail execution and positive consumer response to new innovations.

Its operating profit, also known as earnings before interest, taxes, depreciation, and amortisation (EBITDA), surged 11% to ₹100 crore as against ₹90 crore in the corresponding period last year.

Its EBITDA margin expanded to 27.51% in contrast to 26.58% in the year-ago period.

“We delivered a strong quarter with sustained top-line and bottom-line growth. This growth is enabled by the consumer response to our science-backed superior innovations, new consumer communication initiatives and strengthened go-to-market and supply chain capabilities,” said Milind Thatte, Managing Director, P&G Health India.

Thatte said the company is delivering balanced growth and value creation for stakeholders, driven by a strategy focused on a portfolio of quality, trusted and highly recommended brands where performance drives brand choice. He added that the approach is anchored in superiority across product, packaging, brand communication, retail execution and value.

He further noted that the strategy is supported by constructive disruption, productivity, and an agile and accountable organisation.

P&G Health share price trends

Following the earnings, P&G Health shares slipped 6% to touch an intraday low of ₹6,070 apiece on the National Stock Exchange. At 2:33 PM, the stock was trading at ₹6,145 per share, declining 4.94%.

From the beginning of the year, P&G Health shares have surged 7%. Over a month’s time, the stock has fallen 3%, while it has jumped 18% in the past six months.

Shares of the firm had hit a 52-week high of ₹6,975 on July 15, 2026, and a 52-week low of ₹4,707 on April 6, 2026.

P&G Health has a total market capitalisation of ₹10,208.62 crore as of August 6, 2026, according to data on the NSE.